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Summary
Objective: We tested the hypothesis that human glucocorticoid-induced tumor necrosis factor receptor (hGITR/TR11) expressed on the sur-
face of activated CD4C T cells is responsible for up-regulating the production of matrix metalloproteinase (MMP)-13 by ﬁbroblast-like syno-
viocytes (FLSs).
Methods: The level of MMP-13 was measured by Western blot and reverse transcriptase polymerase chain reaction (RT-PCR). Expressions
of hGITR ligand (hGITRL) on the surface of FLSs and hGITR on the surface of human CD4C T cells were analyzed by ﬂow cytometry and RT-
PCR. Neutralizing antibodies (Abs) were used to block hGITRL and hGITR on the surface of FLSs and human CD4C T cells, respectively.
Human CD4C T cells were cocultured with FLSs to facilitate interaction between hGITR on CD4C T cells and hGITRL on FLSs.
Results: Soluble hGITR (shGITR) stimulated FLSs to produce MMP-13, and blockade of hGITRL reduced this effect. Direct contact between
activated CD4C T and FLSs also induced the production of MMP-13, and neutralization of hGITR on activated CD4C T cells during coculture
decreased the amount of MMP-13 produced by FLSs.
Conclusion: shGITR stimulated FLSs to produce MMP-13 via a signal through hGITRL. Direct contact between activated CD4C T cells and
FLSs facilitated hGITRehGITRL interaction, and resulted in inducing MMP-13. This effect may increase tissue destruction in chronic inﬂam-
mation such as rheumatoid arthritis (RA).
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The glucocorticoid-induced tumor necrosis factor receptor
(GITR), a 66e70 kDa homodimeric glycoprotein, is a mem-
ber of the tumor necrosis factor receptor (TNFR)-nerve
growth factor receptor family induced by dexamethasone
in T cells1. Human GITR (hGITR/TR11) or human GITR li-
gand (hGITRL/TL6) was identiﬁed by searching for homo-
logues in an expressed sequence tag cDNA database2,3.
Although the intracellular domains of TNFR members gen-
erally have no homology, the intracellular domain of GITR
has homology with those of 4-1BB, CD27, and OX40, sug-
gesting that these subfamilies may share signal
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GITR in T cells is similar to these other proteins; GITR ex-
pression is increased on activated T cells. Shimizu et al.6
have demonstrated that GITR is predominantly expressed
on CD25CCD4C regulatory T cells in the thymus and its pe-
riphery, and that monoclonal antibodies against it abrogate
CD25CCD4C T cell-mediated suppression in vitro. In addi-
tion, increased expression of GITR in CD25CCD4C T cells
has been detected using DNA microarrays7. These results
suggest that GITR is involved in the control of immunological
self-tolerance. In addition to its activity in T cells, soluble
GITR (sGITR) activates macrophages and induces nitric ox-
ide synthase8, cyclooxygenase-29, and matrix metalloprotei-
nases (MMPs)10, probably via GITR/GITR ligand interaction.
Rheumatoid arthritis (RA) is a chronic disabling disease of
which progressive destruction of joints and inﬂammations of
the synovial membranes by inﬁltrated immune cells are im-
portant characteristics. Activated ﬁbroblast-like synovio-
cytes (FLSs) in the lining layer of the synovium contribute
to the invasion of articular cartilage and bone. Although nor-
mal intimal ﬁbroblasts have not been shown to produce ma-
trix-degrading enzyme, responses to cytokines in culture and
in situ hybridization studies in diseased tissue suggest
that FLSs secrete MMPs more readily than most other6
147Osteoarthritis and Cartilage Vol. 14, No. 2ﬁbroblasts11. FLSs are characterized by elevated expression
of adhesion molecules and matrix-degrading enzymes. The
latter remove the extra-cellular matrix, providing space for
the FLSs to invade. MMPs are a family of zinc-containing
endo-proteinases; they include the interstitial collagenases,
gelatinases, stromelysins, matrilysin, metalloelastase, and
membrane-type MMPs12. MMPs are important in tissue re-
modeling and wound healing, and their expression is regulat-
ed at the transcriptional level and also by activation. Effects
on MMP expression, either activation, or inhibition by tissue
inhibitors of metalloproteinase (TIMPs), may contribute to
the progression of diseases such as RA, and osteoarthritis
(OA), and to tumor invasion. One of the newest members
of the collagenase subfamily, MMP-13, has been shown to
degrade collagen types I, II, and III, although it prefers colla-
gen type II which is the primary collagen found in articular
cartilage13. Transcripts of MMP-13 were originally isolated
from breast tumors, and it has been found in articular carti-
lage and synovial tissues in patients with OA or RA, but
not in normal tissue. Cultured FLSs from RA tissue express
MMP-13 and can be stimulated with tumor necrosis factor-
a (TNF-a) and interleukin-1b (IL-1b)14.
Activated T cells play a crucial role in the inﬂammatory pro-
cess associated with RA. T cells that are actively recruited
during inﬂammation secrete various cytokines that affect
the functions of other inﬁltrating inﬂammatory cells as well
as resident tissuecells suchasFLSs.Althoughmanyof these
observations stem from the examination of individual cyto-
kines, or membrane proteins of T cells, the effect of the ex-
pression of hGITR on the surface of inﬁltrated T cells has
not been examined yet. We have tested the hypothesis that
hGITR expressed on the surface of activated CD4C T cells
stimulates the production ofMMP-13,which presumably con-
tributes to the pathologic remodeling of the extra-cellular ma-
trix, by FLSs. We demonstrate expression of MMP-13 in FLS
stimulated with soluble hGITR (shGITR) byWestern blot and
reverse transcriptase polymerase chain reaction (RT-PCR),
and show that hGITRL is expressed on the surface of
FLSs. Blockade of hGITRL diminished the level of MMP-13
by inhibiting the effect of shGITR, indicating that up-regula-
tion of MMP-13 involves signaling via the hGITRL in FLSs.
Methods
SYNOVIAL CELL CULTURE
Synovial tissue samples were obtained during operations
on patients with OA and RA. All samples were obtained af-
ter receiving informed consent. This study was done after
approval of the Institutional Ethics Committee of Ulsan Uni-
versity Hospital. Synoviocyte cultures were prepared as de-
scribed15 with modiﬁcations. Samples were cut into small
pieces and dissociated enzymatically with collagenase
(0.5 mg/ml, Sigma Chemical Co.) for 16 h at 37(C. The
cells obtained were plated on culture dishes in Dulbecco’s
MEM (DMEM) supplemented with 10% fetal bovine serum
(FBS) and allowed to adhere. To eliminate nonadherent
cells, the cells were cultured for 48 h, and then washed thor-
oughly with phosphate-buffered saline (PBS). The adherent
synovial cells were grown to conﬂuence, trypsinized and
passaged in 150-cm2 culture dishes. Synovial cells collected
at the fourth to eighth passages were used in subsequent
experiments. They were a homogenous population of
FLSs, and less than 1% reacted with anti-CD45 monoclonal
antibody (mAb), or anti-CD11b mAb (data not shown).
MH7A cells, an established cell line obtained from RApatients and transfected with SV40 T antigen (Riken Cell
Bank, Japan), were used as an FLS cell line. They were
grown in RPMI-1640 medium and supplemented with 10%
FBS. Cells (105 cells/well) were stimulated with the indicat-
ed concentrations of shGITR (human TR11-Fc: KOMED,
Seoul, Korea).
T CELL CULTURES
Peripheral blood mononuclear cells (PBMCs) were ob-
tained in the form of buffy coats from the Ulsan Red Cross
Blood Center and further puriﬁed by separation on Histopa-
que (1.077 g/ml) lymphocyte separation medium. CD4C T
cells were puriﬁed using the MACS magnetic separation
system according to the manufacturer’s instructions (Mil-
tenyi Biotech). Cells were resuspended at 108 cells/ml in
PBS containing 5% FBS, incubated with antihuman CD4C
mAb conjugated with biotin (B.D. Pharmingen), and collected
by incubating with streptavidin-microbeads at 4(C for
15 min. LS columns (Miltenyi Biotech) were used to select
the CD4C T cells, which were routinely O95% pure by
ﬂow cytometry. Human CD4C T cells were incubated at
106 cells/ml in medium with or without phorbol myristate ac-
etate (PMA) (5 ng/ml) and ionomycin (200 ng/ml) or phyto-
hemagglutinin (PHA) (5 mg/ml) for 48 h. For coculture with
FLSs, CD4C T cells were ﬁxed on ice with 1% paraformal-
dehyde in PBS for 2 h and washed three times with PBS.
IMMUNOBLOT ANALYSIS
Samples were separated by sodium dodecyl sulfate-poly-
acrylamidegel electrophoresis (SDS-PAGE)without a reduc-
ing agent and transferred onto nitrocellulose membranes.
Some samples were concentrated up to 10-fold by ultraﬁltra-
tion using membrane units with a molecular weight limit of
10,000 Da (Sigma Chemical Co.). Equal aliquots of the con-
ditioned media, relative to cell number were analyzed for the
amount of MMP-13 by Western blotting, using a polyclonal
rabbit Ab against human MMP-13 (Chemicon International,
Temacula, CA)16. The blots were then washed in TriseTw-
een buffered saline (TTBS, 20 mMTriseHCl, pH 7.6 contain-
ing 137 mM NaCl and 0.05% (v/v) Tween 20), blocked
overnight with 5% (w/v) bovine serum albumin (BSA), and
probed with polyclonal antibody (Ab) to MMP-13 in 5% (w/
v) BSA dissolved in TTBS. Ab-reactive proteins were de-
tected by enhanced chemiluminescence using horse-radish
peroxidase-conjugated secondary anti-rabbit Ab. Antihuman
MMP-13 recognizes the latent proenzyme at 60 kDa as well
as the active form at 48 kDa. The levels of immunoreactive
pro-MMP-13 were quantitated by densitometric scanning of
ﬁlms using an image analyzer.
RNA ISOLATION AND RT-PCR
Expressions of hGITR, hGITRL, MMP-1, MMP-13, tissue
inhibitor of metalloproteinase-1 (TIMP-1), TIMP-2, and glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) mRNAs
were assessed by RT-PCR. RNA was isolated with TRI re-
agent (Sigma Chemical Co.). Total RNA was used for cDNA
synthesis using the reverse transcriptase in the cDNA syn-
thesis kit (Invitrogen, San Diego, CA). The cDNAs were am-
pliﬁed by PCR for 30 cycles (hGITRL, MMP-1, TIMP-1, and
TIMP-2), 35 cycles (hGITR, and MMP-13), and 25 cycles
(GAPDH) with the PCR primers listed in Table I. Each cycle
consisted of 30 s of denaturation at 94(C, 30 s of annealing
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PCR primers used in the study
Gene Sense primer Antisense primer
HGITR 5#-GAGTGGGACTGCATGTGTGT-3# 5#-ACAGCGTTGTGGGTCTTGTT-3#
HGITRL 5#-AAGCTGTGGCTCTTTTGCTC-3# 5#-ATACAGCCGCACCTCAAAAG-3#
MMP-1 5#-CACAGCTTTCCTCCACTGCTGCTGC-3# 5#-GGCATGGTCCACATCTGCTCTTGGC-3#
MMP-13 5#-TGGTGGTGATGAAGATGATTTGTCT-3# 5#-AGTTACATCGGACCAAACTTTGAAG-3#
TIMP-1 5#-CCTGGCTTCTGGCATCCTGTT-3# 5#-GGGACCTGTGGAAGTATCCGC-3#
TIMP-2 5#-CAGTGAGAAGGAAGTGGACTC-3# 5#-CATCTGGTACCTGTGGTTCAG-3#
GAPDH 5#-CCACCCATGGCAAATTCCATGGCA-3# 5#-TCTAGACGCCAGGTCAGGTCCACC-3#
Key : GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase.at 60(C, and 30 s of extension at 72(C. GAPDH was used
as internal control. The sizes of the PCR products for
hGITR, hGITRL, MMP-1, MMP-13, TIMP-1, TIMP-2, and
GAPDH were 250, 281, 396, 376, 280, 300, and 600 bp,
respectively.
FLOW CYTOMETRY
Cells (106/sample) were incubated in PFS buffer (phos-
phate based saline, 2.5% FBS, and 0.1% sodium azide)
with anti-hGITR Ab (KOMED) (rat immunoglobulin (IgG):
isotype control), and anti-hGITRL Ab (KOMED) (rabbit
IgG: isotype control) on ice for 30 min to detect hGITR,
and hGITRL, respectively. The cells were washed three
times in PFS, and incubated on ice for 30 min with ﬂuorescein
isothiocyanate (FITC)-conjugated goat anti-rat IgG, and
FITC-conjugated goat anti-rabbit IgG to detect hGITR, and
hGITRL, respectively. They were then washed again as
above, and ﬂow cytometry was performed using an FACS
Calibur (Becton Dickinson).
Results
shGITR STIMULATES SECRETION OF MMP-13
We previously demonstrated that sGITR stimulates mu-
rine macrophages via a signal through the GITR ligand17.
It also induces inﬂammation in mice18, and the expression
of MMP-9 in murine macrophages10. In order to investigate
the role of hGITR in chronic inﬂammations such as RA, we
treated FLSs with shGITR and measured the expression of
MMP by Western blotting. shGITR-induced MMP-13 in
a dose and time-dependent manner, and production of
MMP-13 was maximal at 1000 ng/ml shGITR [Fig. 1(A)].
High concentration of shGITR induced the secretion of la-
tent proenzyme at 60 kDa as well as active form at
48 kDa. MMP-13 production was detectible at 15 h after
shGITR stimulation and the level increased thereafter
[Fig. 1(A)]. Mouse 4-1BB-Fc-treated FLSs, as a negative
control, did not produce MMP-13, whereas PMA- or TNF-
a-treated FLSs, as positive controls, produced substantial
or similar level of MMP-13, respectively, comparing with
shGITR-treated one [Fig. 1(A)]. To assess whether
shGITR-induced MMP-13 production required de novo pro-
tein synthesis, we treated FLSs with shGITR in the pres-
ence of cycloheximide. No signiﬁcant retardation of cell
growth was observed in cycloheximide-treated cells. As
shown in Fig. 1(A), cycloheximide abrogated the stimulatory
effect of shGITR on MMP-13 production. This shows that
newly synthesized protein is required for, or involved in,
the induction of MMP-13 by shGITR. The level of MMP-13
transcripts in the FLSs was measured by RT-PCR. MMP-
13 mRNA increased in a time-dependent manner inresponse to shGITR. It was detectible at 8 h, and reached
a maximum at 15e24 h after stimulation [Fig. 1(B)]. Fifteen
hours of shGITR stimulation had no effect on the levels of
MMP-1, TIMP-1, and TIMP-2 transcripts in FLS, where
MMP-1, TIMP-1, and TIMP-2 were constitutively expressed
[Fig. 1(C)].
We used a primary RA-FLS and an immortalized rheuma-
toid FLS cell line, MH7A, to see whether shGITR also in-
creased the expression of MMP-13. A similar pattern of
MMP-13 protein secretion was observed in the MH7A cells
and primary RA-FLSs [Fig. 2(A) and (B)]. However, in con-
trast with the OA-FLSs, MMP-13 transcripts were constitu-
tively expressed in MH7A cells and primary RA-FLSs,
though at a low level, and started to increase within 6 h of
shGITR stimulation [Fig. 2(C)].
shGITR TRANSMITS A SIGNAL THROUGH hGITRL IN FLSs
We tested for the presence of hGITR and hGITRL in pri-
mary FLS and MH7A cell lines to examine whether hGITR/
hGITRL signaling may play a role in ﬁbroblasts. FACS anal-
ysis showed that substantial levels of hGITRL were ex-
pressed constitutively on the surface of primary FLS and
MH7A cells, whereas no hGITR was detected on them
[Fig. 3(A)]. A similar pattern was observed for transcript lev-
els determined by RT-PCR [Fig. 3(B)].
Since FLSs express hGITRL constitutively, shGITR could
transmit a signal through it. To determine whether hGITRL
stimulatesMMP-13production inFLSs,weaddedapolyclon-
al Ab that neutralizes hGITRL to the FLSs in the presence of
shGITR. Production of MMP-13 induced by shGITR was in-
hibited by treatment of this Ab in a dose-dependent manner,
but not by rabbit IgG (Fig. 4). These results demonstrate that
shGITR stimulates MMP-13 expression in the FLSs via a
signal through hGITRL.
MMP-13 PRODUCTION IS MODULATED BY DIRECT CELL
CONTACT BETWEEN T LYMPHOCYTES AND FLS VIA
hGITRehGITRL INTERACTION
Contact with stimulated T cells strongly induces MMPs in
FLSs, a mechanism that is highly relevant to tissue remod-
eling in chronic inﬂammation. The observed effect of
shGITR on expression of MMP-13 in FLSs led us to inves-
tigate whether induction could be due to direct cell contact
between activated T cells and FLSs via hGITRehGITRL in-
teraction during chronic inﬂammation. We ﬁrst determined
whether stimulation with PMA/ionomycin (PMA/I) elevated
the level of hGITR on the surface of human CD4C T cells.
It has been reported that GITR is mainly expressed on
CD4C T cells, although it is constitutively expressed on
both conventional CD4C and CD8C T cells19. hGITR was
found to be constitutively expressed on the surface of
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tially after 2 days of stimulation with PMA/I [Fig. 5(A)]. The
level of hGITR transcripts also increased after stimulation
[Fig. 5(B)]. Next, we investigated the effect of direct cellecell
interaction on the production of MMP-13. Coculture of FLSs
with paraformaldehyde-ﬁxed human CD4C T cells resulted
in MMP-13 production, whereas none was found in the
absence of T cells. Coculture of FLSs with both of ﬁxed
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Fig. 1. Effect of shGITR on MMP-13 levels in FLSs. (A) FLSs
(105 cells/well) were stimulated with shGITR (0, 20, 100, 500, and
1000 ng/ml) for 48 h, or with 500 ng/ml shGITR for 0, 15, 24, and
48 h without FBS. Cells (105 cells/well) were incubated for 48 h
with murine 4-1BB-Fc (100 ng/ml) and PMA (100 ng/ml) or TNF-
a (100 ng/ml) as negative and positive controls, respectively, com-
paring with shGITR (100 ng/ml). Cells (105 cells/well) were incubat-
ed with 1 mg/ml cycloheximide in the presence or absence of
200 ng/ml shGITR for 48 h. After incubation, 100 ml samples of
the medium were concentrated by ultraﬁltration (10-fold), separated
on 10% SDS-PAGE gels and analyzed for MMP-13 by Western
blotting as described in the Methods section. (B) FLSs (106 cells/
well) were stimulated with 100 ng/ml of shGITR for 0, 8, 15, and
24 h. Total RNA was extracted and subjected to RT-PCR analysis
for MMP-13. (C) Cells incubated with shGITR for 0 and 15 h were
analyzed for MMP-1, TIMP-1, and TIMP-2. Similar results were ob-
tained in three independent experiments. Figures above the signals
represent the arbitrary densities of pro-MMP-13 expression.PMA/I-activated and unstimulated (US) CD4C T cells pro-
duced MMP-13, and higher level was observed in FLS
cocultured with stimulated CD4C T cells [Fig. 6(A)]. There
was no difference between CD4C T cells stimulated by
PMA/I and those by PHA [Fig. 6(B)]. In order to identify
the molecules present on activated CD4C T cells that
were likely to be responsible for the induction of MMP-13,
we used a neutralizing Ab against hGITR. As shown in
Fig. 6(C), blockade of hGITR on the activated CD4C T cells
reduced the level of MMP-13, although it did not completely
abolish it, comparing with the treatment of rat IgG.
Discussion
We have shown that shGITR activates FLS to secrete
MMP-13. Up-regulation of MMP-13 production was also
conﬁrmed with a primary FLS and an immortalized FLS
cell line, MH7A, from RA patients. Induction of MMP-13
by shGITR was enhanced at the level of transcription.
Micro-satellite marker analysis, using sib-pair linkage, has
implicated non-HLA-linked loci in human chromosome
1p36 in RA20. This locus contains the genes for 4-1BB,
CD30, DR3, and CD40, and the gene for hGITR is present
in human chromosome 1p36.321, although there has been
no evidence of an association of hGITR and hGITR poly-
morphisms with RA. Although sGITR has not been
detected in any inﬂammatory disease or RA patient, it
could be involved in inﬂammatory processes, since sGITR
activates murine macrophages to generate nitric oxide,
prostaglandin E2 (PGE2), and MMP-9
8e10. A soluble form
of TNFR or of a TNF family protein has been detected in
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Fig. 2. Effects of shGITR on MMP-13 levels in MH7A and RA-FLS.
(A) MH7A cells (105 cells/well) were stimulated with shGITR (0, 50,
and 200 ng/ml) or PMA (100 ng/ml) for 48 h without FBS. Cells
(105 cells/well) were stimulated with 100 ng/ml shGITR for 0, 8,
15, 24, and 48 h without FBS. (B) RA-FLS cells (5! 104 cells/
well) were stimulated with shGITR (0, 50, 200, and 500 ng/ml) for
48 h without FBS. After incubation, medium samples of 100 ml
were concentrated by ultraﬁltration (10-fold), separated on 10%
SDS-PAGE gels and analyzed for MMP-13 by Western blotting
as described in the Methods section. (C) Cells (106 cells/well)
were stimulated with 100 ng/ml of shGITR for 0, 6, and 15 h. Total
RNA was extracted and subjected to RT-PCR analysis for MMP-13.
Similar results were obtained in three independent experiments.
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Fig. 3. Expression of hGITR and hGITRL on FLS and MH7A cells. (A) FLS or MH7A cells (106 cells/well) were prepared as described in the
Methods section and stained with anti-hGITR Ab (2), or anti-hGITRL Ab (3) to detect hGITR [rat IgG: isotype control (1)] or hGITRL [rabbit IgG:
isotype control (1)], respectively. The cells were further incubated with FITC-conjugated goat anti-rat IgG or FITC-conjugated goat anti-rabbit
IgG for detection of hGITR and hGITRL, respectively, and analyzed by ﬂow cytometry. (B) Total RNA was extracted from OA-FLS, RA-FLS,
and MH7A cells (106 cells/well) and subjected to RT-PCR. Both cells contain transcript of hGITRL, but not hGITR. Similar results were ob-
tained in three independent experiments.immuno-pathological disease conditions. Soluble forms of
surface receptors can be produced either by proteolysis of
membrane-bound receptors, or by alternatively spliced tran-
scripts encoding soluble forms of receptors. In the case of
GITR, an alternatively spliced transcript encoding the solu-
ble form has been reported22. With regard to other TNFR
family proteins, an elevated level of soluble CD27 as well
as an increase in the number of CD27 negative T cells
were found in synovial ﬂuid in RA, suggesting that activated
T cells produce a soluble form of CD2723. Soluble 4-1BB
has also been found in the sera of patients with RA24.
Some ligands of the TNF superfamily have been shown
to transmit signals in both directions through their respec-
tive receptors into cells that express the corresponding
ligand, although the mechanism for ligand signaling back
into cells is unknown. Since in TNFR and ligand families,
the receptors as well as the ligands are membrane-bound
molecules, a bidirectional transduction of signals is possi-
ble. Bidirectional signals through the receptor as well as
the ligand have been described for the OX40, CD40, andCD30 receptor/ligand systems. Reverse signaling through
CD30 ligand activates neutrophils to produce IL-8 and a rapid
oxidative burst25. The signal through 4-1BB ligand inhibits
osteoclast formation by interfering with the phosphatidylino-
sitol 3-kinase pathway26. Transgenic mice expressing
OX40 ligand developed experimental autoimmune enceph-
alomyelitis, indicating a pivotal role for OX40 ligand in the
pathogenesis of this disease27. hGITRL was originally
cloned and expressed in endothelial cells3, whereas the
recently cloned GITR ligand was shown to be expressed
in murine macrophages and dendritic cells28. Since hGITRL
was constitutively expressed on the surface of primary FLS
and MH7A cell lines, whereas hGITR was not detectible,
the response induced by shGITR could be due to a signal
through hGITRL. To establish whether shGITR-stimulated
MMP-13 production was caused by signal transduction
through hGITRL, we examined the effect of shGITR after
blocking hGITRL with a polyclonal anti-hGITRL Ab. Neutral-
ization of hGITRL signiﬁcantly diminished the effect of
shGITR, though it did not block it completely, indicating
151Osteoarthritis and Cartilage Vol. 14, No. 2that hGITRL plays a role in the expression of MMP-13
induced by shGITR. We also showed previously that growth
inhibition of murine macrophages by sGITR was due to
a signal through GITR ligand17. T lymphocytes receive an
activation signal from GITR, leading to proliferation19. FLS
express hGITRL and are activated by cross-linking of the
hGITRL. A plot of reverse signaling could be that T lympho-
cytes and FLS mutually activate each other via interaction
of receptor on lymphocytes with its ligand on FLS, leading
to an enhancement and maintenance of an immune
response such as chronic inﬂammation.
We have not determined a signaling pathway down-
stream of hGITRL to generate MMP-13. In case of proin-
ﬂammatory cytokines, they elicit a series of shared
phosphorylation events to facilitate transcriptional induction
of MMP-13 beyond the particularities of their receptors. The
shGITR             - + + + +
Anti-hGITRLAb   - - - [ug/ml]1 5
rabbit IgG - - + - -
MW (kDa)
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Fig. 4. The effect of neutralizing Ab against hGITRL on MMP-13
production by FLSs. FLS cells were prepared as described in the
Methods section, and were incubated in 24-well plates (105 cells/
well) for 48 h with polyclonal anti-hGITRL Ab (1, 5 mg/ml) or rabbit
IgG (1 mg/ml) in the presence of shGITR (200 ng/ml). After incuba-
tion, medium sample of 200 ml was concentrated by ultraﬁltration
(20-fold), incubated with protein G to remove remaining IgG, sepa-
rated on 10% SDS-PAGE gels, and was analyzed for MMP-13 by
Western blotting. Figures above the signals represent the arbitrary
densities of pro-MMP-13 expression.promoter of MMP-13 contains a TATA box at approximately
30 bp, and an AP-1 site at approximately 70 bp29. Mu-
rine sGITR activated protein kinase Cd and phospholipase
D to generate MMP-9 in macrophages30. MMP-13 expres-
sion is also regulated through protein kinase C-dependent
pathway31 and protein kinase C is regarded as a potential
inducer of AP-1. It is likely that shGITR-stimulated
MMP-13 induction could be under the control of AP-1.
Degradation of articular cartilage is a characteristic of RA.
Since MMPs are extremely efﬁcient in cleaving cartilage
components, they are considered to play a critical role in
the pathogenesis of RA. Of the members of the MMP sub-
family, MMP-1 and MMP-13 play major roles in this degra-
dation. The level of MMP-13 induced by shGITR was similar
to that generated by TNF-a in FLS. TNF-a has been demon-
strated to be predominantly involved in the initiation and
progression of articular cartilage destruction. The ability of
TNF-a is to promote the synthesis and release of matrix-
degrading proteases by human chondrocytes and synovial
cells. Among these, the collagenase subfamily including
MMP-13 has been demonstrated to play a pivotal role in
cartilage destruction13. MMP-13 is highly overexpressed
in chondrocytes and synovial cells32. Since we have not
determined shGITR-stimulated MMP-13 by human articular
chondrocytes, we cannot say whether there is quantitative
difference of MMP-13 level between chondrocytes and sy-
novial cells. However, the localization of MMP-13 implicates
its speciﬁc roles. Synovial production of MMP-13 is impor-
tant in the pathogenesis of both arthritides (RA and OA),
and in the articular cartilage, MMP-13 participates in tissue
remodeling33. We found that FLSs from OA patient failed to
express transcripts of MMP-13, whereas RA-FLS and
MH7A cells expressed MMP-13, though at a low level. At
the protein level, secretion of MMP-13 was not detected
in US RA-FLS and MH7A cells, probably because of itsPMA+I for 2 dnone
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Fig. 5. Expression of hGITR on CD4C T cells. (A) CD4C T cells (3! 106 cells/well) were stimulated with PMA (5 ng/ml) and ionomycin
(200 ng/ml) for 2 days and stained with anti-hGITR Ab (2) to detect hGITR [rat IgG: isotype control (1)]. The cells were further incubated
with FITC-conjugated goat anti-rat IgG, and analyzed by ﬂow cytometry. (B) Cells (107 cells/well) were stimulated with PMA (5 ng/ml) and
ionomycin (200 ng/ml) for 0, 12, and 24 h. Total RNA was extracted and subjected to RT-PCR analysis. Similar results were obtained in three
independent experiments.
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a source of MMP-13 in vivo when inﬂammatory molecules
are present in large quantities due to inﬁltration of immune
cells. The etiologies of RA and OA are different, in that
RA is caused by immune dysfunction and chronic inﬂamma-
tion, while OA is the consequence of years of mechanical
stress on the articular cartilage. However, a common fea-
ture of these two diseases is the proteolytic degradation
and ultimate destruction of articular cartilage. Inﬁltrated
immune cells or mechanical insult causes cytokine expres-
sion by connective tissue cells such as synovial ﬁbroblast to
produce MMPs14,34. Although there are profound intrinsic
differences between synovial ﬁbroblasts from different
sources, we showed that primary OA-FLS and RA-FLS
cells and a transformed cell line, MH7A, act in a similar pat-
tern with respect to MMP-13 in response to shGITR.
In many inﬂammatory diseases where tissue remodeling
occurs, mesenchymal cells are in close contact with inﬁl-
trated T cells. The mechanism by which T cells contribute
to synovial inﬂammation in RA has not been clariﬁed. How-
ever, the recognized HLA associations and the clinical efﬁ-
cacy of T cell-targeted therapies implicate T cells in
promoting RA synovitis35. Inﬁltrated T cells may induce in-
ﬂammation through the release of inﬂammatory mediators,
particularly cytokines, or through pathways dependent on
cell contact. T cells can stimulate adjacent cells and modu-
late the activity of a variety of cell types by cell contact36.
The role of CD4C T cells has been demonstrated by the
ﬁnding that the response to anti-CD4 treatment is correlated
with the proportion of synovial CD4C T cells coated by
Ab37. It is likely that local positive feedback loops are
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Fig. 6. Effect of direct contact with CD4C T cells on MMP-13 induc-
tion by FLSs. (A) Conﬂuent FLSs (105 cells/well) were cultured for
48 h either alone or in the presence of US CD4C T cells or PMA/I(5/
200 ng/ml)-stimulated (S) ones (2! 106 cells/well). (B) Human
CD4C T cells were stimulated with PMA/I or PHA (5 mg/ml). (C)
PMA/I-stimulated CD4C T cells were pre-incubated with anti-hGITR
Ab (10 mg/ml) or rat IgG (10 mg/ml) for 8 h, and incubated with FLSs
for 48 h. The CD4C T cells were ﬁxed as described in the Methods
section; before coculture with FLS for 48 h. After incubation, medi-
um samples of 50 ml each were concentrated by ultraﬁltration
(5-fold), separated on 10% SDS-PAGE gels and analyzed for
MMP-13 by Western blotting. Similar results were obtained in three
independent experiments.generated, since FLSs activated by T cells in turn produce
cytokines capable of activating T cells. In this work we dem-
onstrated that membrane-associated hGITR is involved in
activating FLSs to produce MMP-13 when they interact
with CD4C T cells, since blockade of hGITR decreased
the production of MMP-13 by the FLSs. Because neutraliza-
tion of hGITR on the surface of CD4C T cells did not com-
pletely prevent the production of MMP-13, unknown cell
surface factors may be required for CD4C T cells to stimu-
late the production of MMP-13 by FLSs. Thus the interac-
tion between hGITR on CD4C T cells and hGITRL on
FLSs could play a substantial role in the production of
MMP-13, and this may lead to the extra-cellular matrix deg-
radation characteristic of RA.
In summary we have reported that shGITR stimulates
FLSs to produce MMP-13, and the signal involved is trans-
mitted through hGITRL. We also demonstrated an important
role in MMP-13 production of contact between hGITR on
the surface of CD4C T cells and hGITRL on FLSs. Direct
contact between activated CD4C T cells and FLSs induces
the production of MMP-13 responsible for degradation of
type II collagen, a component of the extra-cellular matrix,
and this may augment tissue destruction in chronic inﬂam-
mations such as RA.
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